Albuterol MDPI
Sponsors
Teva Branded Pharmaceutical Products R&D, Inc.
Conditions
Asthma
Phase 3
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
CompletedNCT01424813
Start: 2012-12-31End: 2013-11-30Updated: 2015-06-26
Safety Study of Albuterol Spiromax® in Subjects With Asthma
CompletedNCT01698320
Start: 2012-10-31End: 2013-12-31Updated: 2015-08-19
Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics
CompletedNCT01747629
Start: 2012-12-31End: 2013-11-30Updated: 2015-06-26
A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics
CompletedNCT02126839
Start: 2014-05-31End: 2015-02-28Updated: 2021-11-09